PYPD
Polypid Ltd

935
Mkt Cap
$67.25M
Volume
60,542.00
52W High
$5.12
52W Low
$2.30
PE Ratio
-1.87
PYPD Fundamentals
Price
$4.25
Prev Close
$4.23
Open
$4.24
50D MA
$4.43
Beta
0.32
Avg. Volume
47,706.03
EPS (Annual)
-$2.09
P/B
7.02
Rev/Employee
$0.00
$60.64
Loading...
Loading...
News
all
press releases
PolyPid (NASDAQ:PYPD) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded PolyPid from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Moderate Buy" by Analysts
Shares of PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, MarketBeat...
MarketBeat·11d ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 44.8% in January
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a significant increase in short interest in January. As of January 30th, there was short interest totaling 27,918 shares, an increase of...
MarketBeat·18d ago
News Placeholder
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $13.00 price objective on shares of PolyPid in a research report on Wednesday...
MarketBeat·22d ago
News Placeholder
PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS
PolyPid (NASDAQ:PYPD - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.07...
MarketBeat·22d ago
News Placeholder
PolyPid Q4 Earnings Call Highlights
PolyPid (NASDAQ:PYPD) said 2025 marked a pivotal year as the company completed its SHIELD II Phase 3 trial and moved D-PLEX100 into the final stages of regulatory preparation, while also advancing...
MarketBeat·22d ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Sees Large Decrease in Short Interest
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totaling 19,282 shares, a drop of 71.7...
MarketBeat·1mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Given Average Recommendation of "Moderate Buy" by Brokerages
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com reports...
MarketBeat·2mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 72.2% in December
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 63,411 shares, an...
MarketBeat·2mo ago
News Placeholder
PolyPid Appoints Brooke Story As Chairman Of Board
(RTTNews) - PolyPid Ltd. (PYPD), a late-stage biopharma company, Tuesday announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025...
Nasdaq News: Markets·3mo ago
<
1
2
...
>

Latest PYPD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.